Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-01-14

Clinical Trial Update: Noninvasive Monitoring of Cerebral Blood Flow Autoregulation in Patients With Traumatic Brain Injury (TBI)

View source ↗

Summary

This clinical trial evaluating noninvasive monitoring of cerebral blood flow autoregulation in patients with traumatic brain injury has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Advanced Brain Monitoring, Inc. | Conditions: Traumatic Brain Injury (TBI) | Status: WITHDRAWN